Keyphrases
Overexpression
100%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
100%
Eyelid
100%
Sebaceous Carcinoma
100%
Cyclin E1
100%
Cyclin-dependent Kinase 1 (CDK1)
100%
Sebaceous Adenoma
50%
Quantitative PCR
25%
Polymerase Chain Reaction Analysis
25%
Gene Network
25%
Gene chip
25%
Expression Level
12%
Tissue Sampling
12%
Cell Viability
12%
Molecular Mechanism
12%
High-level Expression
12%
Knowledge Base
12%
Histopathological Examination
12%
Microarray Analysis
12%
Cell Cycle Progression
12%
Cell Cycle Genes
12%
Tumor Viability
12%
Unique Genes
12%
Global Gene Expression Analysis
12%
Surgical Tissues
12%
Gene Overexpression
12%
Pathway Knowledge
12%
Ingenuity
12%
Pathogenic Pathways
12%
Functional Types
12%
Category Analysis
12%
Medicine and Dentistry
Proliferating Cell Nuclear Antigen
100%
Eyelid
100%
Sebaceous Carcinoma
100%
Cyclin Dependent Kinase Inhibitor 2A
100%
Cyclin-Dependent Kinase 1
100%
Sebaceous Adenoma
50%
Reaction Analysis
25%
Real-Time Polymerase Chain Reaction
25%
Neoplasm
12%
Cell Viability
12%
Microarray Analysis
12%
Gene Expression Profiling
12%
Cell Cycle
12%
Base
12%
Cell Cycle Progression
12%
Nursing and Health Professions
Cycline
100%
Sebaceous Carcinoma
100%
Cyclin Dependent Kinase Inhibitor 2A
100%
Cyclin Dependent Kinase 1
100%
Adenoma
50%
Real Time Polymerase Chain Reaction
25%
Reaction Analysis
25%
Neoplasm
12%
Microarray Analysis
12%
Knowledge Base
12%
Gene Expression Assay
12%
Biochemistry, Genetics and Molecular Biology
Cyclin-Dependent Kinase
100%
Sebaceous Gland
100%
Cyclin E1
100%
Cyclin-Dependent Kinase 1
100%
Real-Time Polymerase Chain Reaction
25%
Gene Network
25%
Gene Expression Profiling
12%
Microarrays
12%
Cell Cycle
12%
Cell Viability
12%
Cell Cycle Progression
12%
Knowledge Base
12%
Neuroscience
Proliferating Cell Nuclear Antigen
100%
Cyclin-Dependent Kinase
100%
Eyelid
100%
Cyclin Dependent Kinase 1
100%
Real-Time Polymerase Chain Reaction
28%
Gene Expression
14%
Cell Viability
14%
Expression Analysis
14%
Microarrays
14%
Cell Cycle
14%
Cell Cycle Progression
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cycline
100%
Sebaceous Carcinoma
100%
Cyclin Dependent Kinase Inhibitor 2A
100%
Cyclin Dependent Kinase 1
100%
Adenoma
50%
Neoplasm
12%
Cell Viability
12%
Base
12%